TAZORAC
NDC 16110-915, tazarotene, cream, from Almirall, LLC.
- Product NDC
- 16110-915
- Status
- Listed
- Labeler
- Almirall, LLC
- Dosage form
- CREAM
- Route
- CUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021184
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16110-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAZAROTENE.05 mg/g
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16110-915-30 | 16110091530 | 1 TUBE in 1 CARTON (16110-915-30) / 30 g in 1 TUBE |
| 16110-915-60 | 16110091560 | 1 TUBE in 1 CARTON (16110-915-60) / 60 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/021744d1-a6d7-4ad6-99c2-7187c24e64c6
Use it
Look up 16110-915 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16110-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16110-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.